BASILE, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 1.048
NA - Nord America 775
AS - Asia 711
SA - Sud America 141
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.694
Nazione #
US - Stati Uniti d'America 739
RU - Federazione Russa 686
SG - Singapore 248
CN - Cina 233
BR - Brasile 116
IT - Italia 85
HK - Hong Kong 71
VN - Vietnam 69
DE - Germania 56
SE - Svezia 54
FR - Francia 38
IN - India 34
FI - Finlandia 30
GB - Regno Unito 27
NL - Olanda 22
CA - Canada 19
JP - Giappone 16
MX - Messico 16
PL - Polonia 15
ES - Italia 8
IQ - Iraq 8
ZA - Sudafrica 8
AR - Argentina 7
EC - Ecuador 7
BD - Bangladesh 6
ID - Indonesia 6
IE - Irlanda 6
BE - Belgio 4
LT - Lituania 4
TR - Turchia 4
UZ - Uzbekistan 4
AT - Austria 3
CO - Colombia 3
SA - Arabia Saudita 3
TN - Tunisia 3
VE - Venezuela 3
MA - Marocco 2
PH - Filippine 2
PK - Pakistan 2
PY - Paraguay 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
Totale 2.694
Città #
Singapore 147
Dallas 123
Moscow 101
Ashburn 98
Hong Kong 70
San Jose 63
New York 56
Shanghai 43
Beijing 34
Los Angeles 30
Munich 30
Boardman 29
Milan 29
Ho Chi Minh City 28
Hefei 25
Turku 23
Lauterbourg 20
São Paulo 15
Hanoi 14
Tokyo 13
Brooklyn 12
Denver 12
Orem 12
Warsaw 12
Lawrence 11
Princeton 11
Guangzhou 10
Rome 10
Amsterdam 9
Santa Clara 9
Chennai 8
Frankfurt am Main 8
Montreal 8
Pune 8
Houston 7
Johannesburg 7
London 7
Manchester 7
Mexico City 7
Phoenix 7
Toronto 7
Atlanta 6
Columbus 6
Mumbai 6
Seattle 6
The Dalles 6
Da Nang 5
Dublin 5
Helsinki 5
Nuremberg 5
Stockholm 5
Barnet 4
Brussels 4
Erbil 4
Falkenstein 4
Guayaquil 4
Haiphong 4
Hyderabad 4
Poplar 4
Shenzhen 4
Tashkent 4
Belo Horizonte 3
Boston 3
Buffalo 3
Caxias do Sul 3
Cesano Boscone 3
Charlotte 3
Hanover 3
Querétaro 3
Rio de Janeiro 3
Riyadh 3
San Francisco 3
Turin 3
Washington 3
Ankara 2
Bexley 2
Biên Hòa 2
Bến Tre 2
Cancello e Arnone 2
Catania 2
Cerano 2
Chaam 2
Cleveland 2
Council Bluffs 2
Dalian 2
Delhi 2
Detroit 2
Duque de Caxias 2
Hải Dương 2
Jackson 2
Karbala 2
Lappeenranta 2
Mariana 2
Medellín 2
Milwaukee 2
New Delhi 2
Osio Sotto 2
Peschiera Borromeo 2
Pouso Alegre 2
Quito 2
Totale 1.366
Nome #
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 176
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 155
A global approach to improving penile cancer care 130
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 124
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 121
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 119
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 118
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 118
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 116
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 116
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 111
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 109
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 107
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 107
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 101
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 99
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 98
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 95
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 95
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 94
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 93
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 92
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 83
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 60
The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis 56
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer 31
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) 12
null 1
Totale 2.737
Categoria #
all - tutte 11.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 5 0 6 2 0 1 0 1 0 0 9
2022/2023100 27 18 3 7 4 12 8 11 2 0 4 4
2023/2024241 12 20 22 19 15 47 1 40 5 9 14 37
2024/2025483 33 21 16 29 31 41 66 62 70 28 32 54
2025/20261.885 121 124 125 240 182 67 156 188 573 109 0 0
Totale 2.737